|
1
|
Strauch KL and Beckwith J: An Escherichia
coli mutation preventing degradation of abnormal periplasmic
proteins. Proc Natl Acad Sci USA. 85:1576–1580. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pallen MJ and Wren BW: The HtrA family of
serine proteases. Mol Microbiol. 26:209–221. 1997. View Article : Google Scholar
|
|
3
|
Clausen T, Southan C and Ehrmann M: The
HtrA family of proteases: Implications for protein composition and
cell fate. Mol Cell. 10:443–455. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zurawa-Janicka D, Skorko-Glonek J and
Lipinska B: HtrA proteins as targets in therapy of cancer and other
diseases. Expert Opin Ther Targets. 14:665–679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vande Walle L, Lamkanfi M and Vandenabeele
P: The mitochondrial serine protease HtrA2/Omi: An overview. Cell
Death Differ. 15:453–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dewan A, Liu M, Hartman S, Zhang SS, Liu
DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, et al: HTRA1
promoter polymorphism in wet age-related macular degeneration.
Science. 314:989–992. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grau S, Richards PJ, Kerr B, Hughes C,
Caterson B, Williams AS, Junker U, Jones SA, Clausen T and Ehrmann
M: The role of human HtrA1 in arthritic disease. J Biol Chem.
281:6124–6129. 2006. View Article : Google Scholar
|
|
8
|
Tsuchiya A, Yano M, Tocharus J, Kojima H,
Fukumoto M, Kawaichi M and Oka C: Expression of mouse HtrA1 serine
protease in normal bone and cartilage and its upregulation in joint
cartilage damaged by experimental arthritis. Bone. 37:323–336.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chien J, Staub J, Hu SI, Erickson-Johnson
MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH and Shridhar V: A
candidate tumor suppressor HtrA1 is downregulated in ovarian
cancer. Oncogene. 23:1636–1644. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baldi A, De Luca A, Morini M, Battista T,
Felsani A, Baldi F, Catricalà C, Amantea A, Noonan DM, Albini A, et
al: The HtrA1 serine protease is down-regulated during human
melanoma progression and represses growth of metastatic melanoma
cells. Oncogene. 21:6684–6688. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park HJ, Seong YM, Choi JY, Kang S and
Rhim H: Alzheimer's disease-associated amyloid beta interacts with
the human serine protease HtrA2/Omi. Neurosci Lett. 357:63–67.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bakay M, Zhao P, Chen J and Hoffman EP: A
web-accessible complete transcriptome of normal human and DMD
muscle. Neuromuscul Disord. 12(Suppl 1): S125–S141. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ross OA, Soto AI, Vilariño-Güell C,
Heckman MG, Diehl NN, Hulihan MM, Aasly JO, Sando S, Gibson JM,
Lynch T, et al: Genetic variation of Omi/HtrA2 and Parkinson's
disease. Parkinsonism Relat Disord. 14:539–543. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu F, Jin L, Luo TP, Luo GH, Tan Y and
Qin XH: Serine protease HtrA1 expression in human hepatocellular
carcinoma. Hepatobiliary Pancreat Dis Int. 9:508–512.
2010.PubMed/NCBI
|
|
15
|
Clausen T, Kaiser M, Huber R and Ehrmann
M: HTRA proteases: Regulated proteolysis in protein quality
control. Nat Rev Mol Cell Biol. 12:152–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ketteler R, Sun Z, Kovacs KF, He WW and
Seed B: A pathway sensor for genome-wide screens of intracellular
proteolytic cleavage. Genome Biol. 9:R642008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Inagaki A, Nishizawa H, Ota S, Suzuki M,
Inuzuka H, Miyamura H, Sekiya T, Kurahashi H and Udagawa Y:
Upregulation of HtrA4 in the placentas of patients with severe
pre-eclampsia. Placenta. 33:919–926. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soriano P: Generalized lac Z expression
with the ROSA26 Cre reporter strain. Nat Genet. 21:70–71. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chien J, Campioni M, Shridhar V and Baldi
A: HtrA serine proteases as potential therapeutic targets in
cancer. Curr Cancer Drug Targets. 9:451–468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang LJ, Cheong ML, Lee YS, Lee MT and
Chen H: High-temperature requirement protein A4 (HtrA4) suppresses
the fusogenic activity of syncytin-1 and promotes trophoblast
invasion. Mol Cell Biol. 32:3707–3717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hayashi T, Yoshida S, Yoshinaga A, Ohno R,
Ishii N and Yamada T: HtrA2 is up-regulated in the rat testis after
experimental cryptorchidism. Int J Urol. 13:157–164. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Dong F and Hoh J: Loss of
HtrA1-induced attenuation of TGF-β signaling in fibroblasts might
not be the main mechanism of CARASIL pathogenesis. Proc Natl Acad
Sci USA. 112:E16932015. View Article : Google Scholar
|
|
23
|
Hara K, Shiga A, Fukutake T, Nozaki H,
Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T,
et al: Association of HTRA1 mutations and familial ischemic
cerebral small-vessel disease. N Engl J Med. 360:1729–1739. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kato MV: A secreted tumor-suppressor,
mac25, with activin-binding activity. Mol Med. 6:126–135.
2000.PubMed/NCBI
|
|
25
|
Nakamura T, Takio K, Eto Y, Shibai H,
Titani K and Sugino H: Activin-binding protein from rat ovary is
follistatin. Science. 247:836–838. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu SI, Carozza M, Klein M, Nantermet P,
Luk D and Crowl RM: Human HtrA, an evolutionarily conserved serine
protease identified as a differentially expressed gene product in
osteoarthritic cartilage. J Biol Chem. 273:34406–34412. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oka C, Tsujimoto R, Kajikawa M,
Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A,
Kanda H, et al: HtrA1 serine protease inhibits signaling mediated
by Tgfbeta family proteins. Development. 131:1041–1053. 2004.
View Article : Google Scholar : PubMed/NCBI
|
